InstalabLoading...
InstalabLoading...
Your cells make their own built-in defense molecule, and when that defense runs low, things start to go wrong across the body. Low levels have been linked to everything from cognitive decline to cardiovascular events to the gradual piling up of chronic disease as you age. This test gives you an early, exploratory window into how well that defense system is holding up.
This is not a classic clinical test with universally agreed-on cutoffs. It is a research-grade marker that can help you see whether your antioxidant system is keeping pace with the wear and tear of daily life. Think of it as a window into the cellular cost of aging, stress, and chronic illness, rather than a diagnostic verdict.
Total glutathione (GSH, short for the tripeptide gamma-L-glutamyl-L-cysteinyl-glycine) is made inside nearly every cell in your body from three amino acid building blocks: glutamate, cysteine, and glycine. The liver is the main factory, producing and distributing it to the kidneys, lungs, intestine, and brain.
The test captures two forms together: the active form (reduced glutathione, or GSH) and the used-up form (oxidized glutathione, or GSSG). When your cells neutralize damaging molecules, active glutathione gets used up and converted to the oxidized version, which is then recycled back. Total glutathione adds both pools together.
This molecule has several jobs beyond damage control. It helps your liver break down drugs, toxins, and heavy metals for removal. It supports your immune cells, helps regulate cell growth and death, and participates in building DNA and protein. When levels drop, many of these functions suffer at the same time.
The clearest human signal for this biomarker comes from aging research. Levels fall substantially as you get older, and people with lower levels tend to accumulate chronic diseases faster than those with higher levels.
A 6-year study of 2,596 adults aged 60 and older found that people starting with 4 or more chronic diseases had lower serum total glutathione than those with none (3.3 vs 3.6 micromol/L, a unit for very small concentrations in blood). Lower baseline levels were linked to a faster rate of new chronic disease accumulation over the following years. A separate study found that older adults had red blood cell glutathione roughly half that of young adults (1.12 vs 2.08 millimol/L, a unit for slightly higher concentrations).
What this means for you: if you are in your 50s or beyond, a lower number is not just a single abnormal result, it may reflect the biology of how fast chronic conditions are stacking up. People who age well tend to maintain levels closer to those of younger adults.
Several prospective studies link lower glutathione to harder cardiovascular outcomes, including death. In a study of 1,411 adults undergoing heart artery imaging, those with low glutathione had a higher risk of dying during an average 4.7 years of follow-up, with the association holding after adjustment for standard cardiac risk factors.
A Japanese community case-control study (the Hisayama Study) of 134 people with cardiovascular disease and 435 matched comparisons found that those with the highest glutathione levels had about one-quarter the risk of cardiovascular events compared to those with the lowest levels, after adjustment for confounders. In 375 people hospitalized for acute coronary syndrome, each standard deviation increase in an aminothiol score including glutathione raised the risk of a repeat cardiovascular event by about 40% over roughly 2.7 years.
What this means for you: if you already have known heart disease risk factors, a low number adds information beyond a standard lipid panel. It may reflect the oxidative stress that is quietly damaging your blood vessel walls even when cholesterol looks controlled.
The cancer story is counterintuitive. Low circulating glutathione appears to raise risk for some cancers, while high glutathione inside tumor cells helps them resist chemotherapy. In the Norwegian Tromsø 3 study (941 cancer cases, 1,000 subcohort), people with the highest blood total thiol levels, which include glutathione, had about one-third lower risk of lung cancer and about one-third lower risk of breast cancer than those with the lowest levels. Colorectal and prostate cancer associations did not reach statistical significance.
What this means for you: low circulating levels may indicate the kind of chronic oxidative stress that promotes early cancer development. This is not a cancer screening test, but it adds context to your broader risk picture, particularly if you smoke, have a strong family history, or have other risk factors.
Plasma glutathione declines as cognitive function declines in people with mild cognitive impairment, and brain glutathione measured by a specialized MRI technique is lower in people with Alzheimer's disease and mild cognitive impairment than in healthy adults. A meta-analysis confirmed lower central and blood glutathione in people with cognitive decline.
What this means for you: if you have a family history of Alzheimer's or you are noticing early cognitive changes, a low result is one more signal that oxidative stress may be contributing. It is not diagnostic, but it can motivate a more aggressive approach to sleep, exercise, and metabolic health.
No universally standardized clinical reference ranges exist for total glutathione. Different labs use different methods (enzymatic recycling, HPLC, LC-MS/MS), different specimen types (whole blood, plasma, red blood cells), and report in different units. Compare your results within the same lab over time, not across labs.
With that important caveat, the published research points to the following broad ranges.
| Specimen | Research-Reported Range | What It Suggests |
|---|---|---|
| Whole blood (adults) | Approximately 800 to 1,100 micromol/L | Mid-range or higher suggests preserved antioxidant capacity; lower values are more common with aging and chronic disease |
| Plasma (adults) | Approximately 2 to 4 micromol/L | Plasma levels are far lower than whole blood because most glutathione is inside cells |
| Red blood cells (young adults) | Approximately 2.0 millimol/L | Used in aging research as a target; older adults often run closer to 1.1 millimol/L |
Sources: Michelet et al. 1995 (Clinical Chemistry); Richie et al. 1996 (Clinical Chemistry); Sekhar et al. 2011 (American Journal of Clinical Nutrition). These ranges are drawn from published research. Your lab may use different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend.
Age-related decline is well documented, with older adults often showing levels 40 to 50% lower than young adults. Sex differences are inconsistent across studies. Race-related differences appear to exist but are tangled up with diet and other factors.
Because no consensus cutpoint exists, tracking your trend is more useful than any single value. Within-person variability for whole blood glutathione is about 9% across weekly measurements over months, while variation between people is about 20%. A change larger than roughly 25 to 30% from your own baseline is likely a real biological shift, not noise.
Get a baseline now, especially if you are over 40, managing a chronic condition, or starting a supplement aimed at antioxidant support. Retest in 3 to 6 months if you are making changes, then at least annually. Use the same lab each time, collect samples at the same time of day, and note any recent illness, surgery, or intense exercise in the week before testing.
Trending is especially useful because this test does not yet have firm clinical cutpoints. You are building your own reference range. Over several readings, a downward trend is a signal to look at sleep, stress, metabolic health, and whether your cells are getting the raw materials they need to make glutathione.
Sample handling is the single biggest source of unreliable results. Glutathione oxidizes quickly during collection and processing, which can artificially lower your active form and inflate the oxidized form. Labs that use immediate derivatization and modern LC-MS/MS methods produce more reliable numbers than older techniques.
Several acute and short-term factors can distort a single reading. The most common:
Several drugs can shift the number without reflecting a true change in your antioxidant capacity. Captopril (an ACE inhibitor) alters the ratio of active to oxidized glutathione without changing total glutathione, and can make interpretation confusing. High-dose glucocorticoids in people with severe illness can lower glutathione through mechanisms unrelated to your baseline health. N-acetylcysteine supplementation will raise your numbers, which is useful to know about but can mask a true deficiency if you stop and retest. If you take any of these, note them on your test order and consider whether a washout period makes sense before retesting.
Evidence-backed interventions that affect your Total Glutathione level
Total Glutathione is best interpreted alongside these tests.